These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38876093)

  • 1. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.
    Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE
    J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic nose in discrimination of children with uncontrolled asthma.
    Tenero L; Sandri M; Piazza M; Paiola G; Zaffanello M; Piacentini G
    J Breath Res; 2020 Jul; 14(4):046003. PubMed ID: 32512553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis.
    de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ
    J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    Biomarkers; 2019 Feb; 24(1):70-75. PubMed ID: 30074408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.
    Brinkman P; van de Pol MA; Gerritsen MG; Bos LD; Dekker T; Smids BS; Sinha A; Majoor CJ; Sneeboer MM; Knobel HH; Vink TJ; de Jongh FH; Lutter R; Sterk PJ; Fens N
    Clin Exp Allergy; 2017 Sep; 47(9):1159-1169. PubMed ID: 28626990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Bras Pneumol; 2016 Apr; 42(2):143-5. PubMed ID: 27167436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
    Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breathing Rhythm Variations during Wash-In Do Not Influence Exhaled Volatile Organic Compound Profile Analyzed by an Electronic Nose.
    Dragonieri S; Quaranta VN; Carratù P; Ranieri T; Buonamico E; Carpagnano GE
    Molecules; 2021 May; 26(9):. PubMed ID: 34064506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled breath condensate volatilome allows sensitive diagnosis of persistent asthma.
    Cavaleiro Rufo J; Paciência I; Mendes FC; Farraia M; Rodolfo A; Silva D; de Oliveira Fernandes E; Delgado L; Moreira A
    Allergy; 2019 Mar; 74(3):527-534. PubMed ID: 30156012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic Nose Analysis of Exhaled Breath Volatile Organic Compound Profiles during Normoxia, Hypoxia, and Hyperoxia.
    Tondo P; Scioscia G; Di Marco M; Quaranta VN; Campanino T; Palmieri G; Portacci A; Santamato A; Lacedonia D; Carpagnano GE; Dragonieri S
    Molecules; 2024 Sep; 29(18):. PubMed ID: 39339353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
    Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
    Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study.
    Suzukawa M; Ohta K; Sugimoto M; Ohshima N; Kobayashi N; Tashimo H; Tanimoto Y; Itano J; Kimura G; Takata S; Nakano T; Yamashita T; Ikegame S; Hyodo K; Abe M; Chibana K; Kamide Y; Sasaki K; Hashimoto H
    Allergol Int; 2024 Oct; 73(4):524-531. PubMed ID: 38658257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.
    Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ
    PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breathomics from exhaled volatile organic compounds in pediatric asthma.
    Neerincx AH; Vijverberg SJH; Bos LDJ; Brinkman P; van der Schee MP; de Vries R; Sterk PJ; Maitland-van der Zee AH
    Pediatr Pulmonol; 2017 Dec; 52(12):1616-1627. PubMed ID: 29082668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.